Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    The Real Story Behind JPMorgan's Infamous "Whale" Trade

    Here's an insight for you - along with a trademark indictment, of course.

    Take it with a grain of salt, because it's just an educated guess on my part.

    It's about how the infamous London Whale may have been harpooned by spawn from his own pod.

    For those who haven't heard, the London Whale is one of the latest traders to make the headlines. Bruno Iksil was the top trader at JPMorgan Chase's Chief Investment Office (CIO) in London.

    He got the nickname "the London Whale" for the outsized bets he became known for.

    But this is no fish story...

    To continue reading, please click here…


    Read More...
  • jp morgan hedge